Final data from Dimerix’s PARASOL collaboration reinforce proteinuria-based endpoints in its phase III ACTION3 trial of lead ...
Contributed by Tai-ping Sun; received May 6, 2025; accepted July 7, 2025; reviewed by Huilin Li, Makoto Matsuoka, and Claus Schwechheimer ...
Background: Retinoic acid (RA) receptors (RARs) in human lymphocytes modulate the humoral and intestinal immune response by regulating target genes, including CD38, TGM2, and gut-homing markers. The ...
The U.S. Food and Drug Administration has approved a new treatment for advanced breast cancer. Drugmaker Eli Lilly announced Sept. 25 the approval of Inluriyo, an oral estrogen receptor antagonist, to ...
Icahn Genomics Institute, Precision Immunology Institute, Department of Immunology and Immunotherapy, Department of Oncological Sciences, Tisch Cancer Institute, Biomedical Engineering and Imaging ...
Hemoglobin A1c, fasting glucose, body weight, body mass index, and systolic blood pressure decreased with GLP-1 RA use. HealthDay News — In children and adolescents with type 2 diabetes (T2D) or ...
The Food and Drug Administration on Thursday approved a new medicine for breast cancer, clearing Eli Lilly’s Inluriyo for people with a specific genetic mutation. Previously known as imlunestrant, the ...
State Key Laboratory of Natural and Biomimetic Drugs, Chemical Biology Center and School of Pharmaceutical Sciences, Peking University, No. 38, Xueyuan Rd, Beijing 100191, China ...
New research based on adults who were cured of HIV after stem cell transplants may offer hope to ultimately have a global impact on HIV care. A total of 10 individuals with HIV have been cured to date ...
Background: Atopic dermatitis (AD) is a prevalent and difficult-to-cure chronic inflammatory skin condition. The mechanism of Jiawei Zicao Plaster (JZP), a clinically used Traditional Chinese Medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback